Currently Enrolling Case Studies

BRE005 Breast A Phase 3 Open-Label, Randomized,  Study of a Drug versus Treatment of Physician’s Choice  in Patients with Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated NCT02915744
BRE006 Breast A phase 3,  Randomized, Open-Label Trial to Evaluate Efficacy and Safety of a Drug with Endocrine Therapy as Adjuvant Treatment in Patients with Hormone Receptor-Positive, HER2-Negative, Early Breast Cancer NCT03701334
#ENDO001 Endometrial A Phase 1a/1b Study of  an  Antibody, in Patients with Advanced Solid Tumors NCT03514121
ENDO002 Endometrial A  Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of a drug  in Combination with Another Drug Versus Treatment of Physician’s Choice in Participants with Advanced Endometrial Cancer NCT03884101
GAS001 Gastric A Phase 3 Randomized, Double-Blind, Controlled Study Evaluating  a drug  in patients with Previously Untreated Advanced Gastric and Gastroesophageal Cancer NCT03694522
LUN002 Lung NSCLC A Randomized, Double-Blind, Phase 3 Study of chemptherapy  with or without a drug in EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) NCT03515837
LYM005 Lymphoma  A Multi-Center, Open label, Dose Escalation, Phase I/Ib Study to Evaluate the Safety and Efficacy of a Drug in Patients with Relapsed or Refractory Lymphomas NCT03119647
LYM003 Lymphoma A Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a Drug in Combination with Another Drug  in patients with relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL). NCT02367040
MDS001 MDS Low Risk A Phase3,Open-Label,Randomized Study to Compare the Efficiancy and Safety of a Drug  Versus another Drug  for the Treatment of Anemia in  Very Low, Low or Intermediate Risk MDS  who Require Red Blood Cell Transfusions NCT03682536
MM001 Multiple Myeloma Multicenter Phase 2 Study to Evaluate Subcutaneous Drug  in Combination with Standard Multiple Myeloma Treatment Regimens NCT03412565
#OVA004 Ovarian A Phase 1a/1b Study of an  Antibody, in Patients with preiously treated Ovarian Cancer NCT03514121
OVA005 Ovarian A Randomized, Double-Blind, Phase 3 Study Comaparison of Platinum-Based Therapy with Two Drugs Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III of IV Nonmucinous Epithelial Ovarian Cancer NCT03602859
PRO002 Prostate A Phase 1b-2 Study of a Drug in Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer NCT03431350
REN004 Renal A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a drug  as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy NCT03142334